ExonHit Therapeutics, a drug and diagnostics discovery company, announced today that the company has identified new blood markers in collaboration with Roche Applied Science for the detection of bovine spongiform encephalopathy (BSE) or “mad cow” disease in living animals . Full results will be presented at the “2nd Dominique Dormont International Conference” in Paris , 1-3 December 2005.
